{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T14:13:10Z","timestamp":1777558390886,"version":"3.51.4"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>In lung cancer, radiation-induced lung injury (RILI) or radiation pneumonitis (RP) are major concerns after radiotherapy. We investigated the correlation between volumes of RP lesions and their RP grades after radiotherapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and materials<\/jats:title><jats:p>We retrospectively collected data from patients with non-small lung cancer that received curative doses to the thorax without undergoing chest radiotherapy before this treatment course. The post-treatment computed tomography (CT) image was used to register to the planning CT to evaluate the correlation between dosimetric parameters and volume of pneumonia patch by using deformable image registration.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>From January 1, 2019, to December 30, 2020, 71 patients with non-small cell lung cancer with 169 sets of CT images met our criteria for evaluation. In all patient groups, we found the RPv max and RP grade max to be significant (p&amp;lt;0.001). Some parameters that were related to the dose-volume histogram (DVH) and RP were lung Vx (x=1-66 Gy, percentage of lung volume received \u2265x Gy), and mean lung dose. Comparing these parameters of the DVH with RP grade max showed that the mean lung dose and lung V1\u2013V31 were significantly correlated. The cut-off point for the occurrence of symptoms in all patient groups, the RPv max value, was 4.79%, while the area under the curve was 0.779. In the groups with grades 1 and 2 RP, the dose curve of 26 Gy covered \u226580% of RP lesions in &amp;gt;80% of patients. Patients who had radiotherapy in combination with chemotherapy had significantly shorter locoregional progression-free survival (p=0.049) than patients who received radiation therapy in combination with target therapy. Patients with RPv max &amp;gt;4.79% demonstrated better OS (p=0.082).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The percentage of RP lesion volume to total lung volume is a good indicator for quantifying RP. RP lesions can be projected onto the original radiation therapy plan using coverage of the 26 Gy isodose line to determine whether the lesion is RILI.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2023.1130406","type":"journal-article","created":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T05:01:03Z","timestamp":1678683663000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["A novel tool to evaluate and quantify radiation pneumonitis: A retrospective analysis of correlation of dosimetric parameters with volume of pneumonia patch"],"prefix":"10.3389","volume":"13","author":[{"given":"Jing-Wen","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Hui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gee-Chen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy J. W.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.5334\/aogh.2419","article-title":"Global epidemiology of lung cancer","volume":"85","author":"Barta","year":"2019","journal-title":"Ann Glob Health"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2014.58.5380","article-title":"Postoperative radiotherapy for pathologic N2 non\u2013small-cell lung cancer treated with adjuvant chemotherapy: A review of the national cancer data base","volume":"33","author":"Robinson","year":"2015","journal-title":"J Clin Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1200\/jco.19.00201","article-title":"Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non\u2013small-cell lung cancer: Long-term results of a multi-institutional, phase II, randomized study","volume":"37","author":"Gomez","year":"2019","journal-title":"J Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S300267","article-title":"Primary tumor radiotherapy during EGFR-TKI disease control improves survival of treatment na\u00efve advanced EGFR-mutant lung adenocarcinoma patients","volume":"14","author":"Hsu","year":"2021","journal-title":"Onco Targets Ther"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/jto.0b013e318262caf6","article-title":"Radical treatment of non\u2013small-cell lung cancer patients with synchronous oligometastases: Long-term results of a prospective phase II trial (Nct01282450)","volume":"7","author":"De Ruysscher","year":"2012","journal-title":"J Thorac Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1148\/rg.244035160","article-title":"Effects of radiation therapy on the lung: Radiologic appearances and differential diagnosis","volume":"24","author":"Choi","year":"2004","journal-title":"Radiographics"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2010.01.010","article-title":"Radiation pulmonary toxicity: From mechanisms to management","volume":"20","author":"Graves","year":"2010","journal-title":"Semin Radiat Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13014-015-0372-1","article-title":"Validation of varian\u2019s SmartAdapt\u00ae deformable image registration algorithm for clinical application","volume":"10","author":"Ramadaan","year":"2015","journal-title":"Radiat Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3857\/roj.2017.00325","article-title":"Deformable image registration in radiation therapy","volume":"35","author":"Oh","year":"2017","journal-title":"Radiat Oncol J"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2009.10.029","article-title":"Radiation injury of the lung after stereotactic body radiation therapy (SBRT) for lung cancer: A timeline and pattern of CT changes","volume":"79","author":"Linda","year":"2011","journal-title":"Eur J Radiol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1709937","article-title":"Durvalumab after chemoradiotherapy in stage III non\u2013small-cell lung cancer","volume":"377","author":"Antonia","year":"2017","journal-title":"N Engl J Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00877","article-title":"Radiation-induced lung injury (RILI)","volume":"9","author":"Giuranno","year":"2019","journal-title":"Front Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.lungcan.2009.09.006","article-title":"Early and late lung radiographic injury following stereotactic body radiation therapy (SBRT)","volume":"69","author":"Trovo","year":"2010","journal-title":"Lung Cancer"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e318219aac5","article-title":"Radiological changes after stereotactic radiotherapy for stage I lung cancer","volume":"6","author":"Dahele","year":"2011","journal-title":"J Thorac Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204734","article-title":"Assessment and agreement of the CT appearance pattern and its severity grading of radiation-induced lung injury after stereotactic body radiotherapy for lung cancer","volume":"13","author":"Yamamoto","year":"2018","journal-title":"PloS One"},{"key":"B16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1053\/j.seminoncol.2005.03.009","article-title":"Non-small cell lung cancer therapy-related pulmonary toxicity: An update on radiation pneumonitis and fibrosis","volume":"32","author":"Kong","year":"2005","journal-title":"Semin Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2011.06.1963","article-title":"Long-term clinical outcome of intensity-modulated radiotherapy for inoperable non-small cell lung cancer: The MD Anderson experience","volume":"83","author":"Jiang","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.radonc.2013.08.041","article-title":"Time evolution of regional CT density changes in normal lung after IMRT for NSCLC","volume":"109","author":"Bernchou","year":"2013","journal-title":"Radiother Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2020.1869297","article-title":"Evaluation of the relationship between the range of radiation-induced lung injury on CT images after IMRT for stage I lung cancer and dosimetric parameters","volume":"53","author":"Itonaga","year":"2021","journal-title":"Ann Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.06.091","article-title":"Radiation dose\u2013volume effects in the lung","volume":"76","author":"Marks","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3109\/0284186x.2010.541934","article-title":"A new approach to quantifying lung damage after stereotactic body radiation therapy","volume":"50","author":"Palma","year":"2011","journal-title":"Acta Oncol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"20424","DOI":"10.1038\/s41598-020-77552-7","article-title":"Radiomic prediction of radiation pneumonitis on pretreatment planning computed tomography images prior to lung cancer stereotactic body radiation therapy","volume":"10","author":"Hirose","year":"2020","journal-title":"Sci Rep"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/00004728-198402000-00003","article-title":"Radiation-induced pulmonary change: CT findings","volume":"8","author":"Libshitz","year":"1984","journal-title":"J Comput Assist Tomogr"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.150.4.765","article-title":"CT appearance of acute radiation-induced injury in the lung","volume":"150","author":"Ikezoe","year":"1988","journal-title":"AJR Am J Roentgenol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.178.6.1781383","article-title":"Radiation injury of the lung after three-dimensional conformal radiation therapy","volume":"178","author":"Koenig","year":"2002","journal-title":"AJR Am J Roentgenol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14040946","article-title":"Quantitative analysis of radiation-associated parenchymal lung change","volume":"14","author":"Chandy","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13014-021-01857-8","article-title":"High-dose thoracic radiation therapy for non-small cell lung cancer: a novel grading scale of radiation-induced lung injury for symptomatic radiation pneumonitis","volume":"16","author":"Szejniuk","year":"2021","journal-title":"Radiat Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.12.035","article-title":"Prospective study of epidermal growth factor receptor tyrosine kinase inhibitors concurrent with individualized radiotherapy for patients with locally advanced or metastatic non\u2013small-cell lung cancer","volume":"81","author":"Wang","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2014.12.009","article-title":"Synergistic effects of crizotinib and radiotherapy in experimental EML4\u2013ALK fusion positive lung cancer","volume":"114","author":"Dai","year":"2015","journal-title":"Radiother Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2022.02.023","article-title":"Local consolidative therapy versus systemic therapy alone for metastatic non-small cell lung cancer: A systematic review and meta-analysis","volume":"114","author":"Wu","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.4161\/onci.28518","article-title":"Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death","volume":"3","author":"Golden","year":"2014","journal-title":"Oncoimmunology"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.25994","article-title":"Development of radiographic radiation pneumonitis (RP) in non-small cell lung cancer patients treated with stereotactic body radiation therapy (SBRT) may be protective against further disease progression","volume":"14","author":"Wolf","year":"2022","journal-title":"Cureus"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1130406\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T05:01:14Z","timestamp":1678683674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1130406\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,13]]},"references-count":32,"alternative-id":["10.3389\/fonc.2023.1130406"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1130406","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,13]]},"article-number":"1130406"}}